Scully Royalty
15 hedge funds and large institutions have $40.6M invested in Scully Royalty in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 0 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
15% more funds holding
Funds holding: 13 → 15 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.07% less ownership
Funds ownership: 30.76% → 28.7% (-2.1%)
15% less capital invested
Capital invested by funds: $47.8M → $40.6M (-$7.22M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IR
IAT Reinsurance
New York
|
+$2.44M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$560K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$469K |
| 4 |
Morgan Stanley
New York
|
+$222K |
| 5 |
Renaissance Technologies
New York
|
+$74.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$19K |
SRL Hedge Fund Activity: Q4 2021 in Review
15 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Scully Royalty (SRL) for Q4 2021, worth a combined $40.6M — down 15% from $47.8M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SRL positions and 1 closed out — a net gain of 2 holders — while 11 added to existing stakes and 0 trimmed.
The largest buyer was IAT Reinsurance, adding an estimated $2.44M. The largest seller was Northern Trust, exiting entirely with an estimated $19K sold.
- 15 institutional investors held Scully Royalty (SRL) as of Q4 2021, up from 13 in Q3 2021.
- Funds reported $40.6M of Scully Royalty stock for Q4 2021, down 15% quarter-over-quarter.
- 3 funds opened new Scully Royalty positions in Q4 2021 and 1 closed out, a net change of +2 holders.
- The largest Scully Royalty buyer in Q4 2021 was IAT Reinsurance, an estimated $2.44M added.
- The largest Scully Royalty seller in Q4 2021 was Northern Trust, an estimated $19K sold.
Based on aggregated 13F filings for Q4 2021.